Technology
Health
Biotechnology
Diffusion Pharmaceuticals
$2.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.24 (-9.52%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell DFFN and other stocks, options, ETFs, and crypto commission-free!
About DFFN
Diffusion Pharmaceuticals Inc. Common Stock, also called Diffusion Pharmaceuticals, is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. Read More The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
Employees
10
Headquarters
Charlottesville, Virginia
Founded
2001
Market Cap
8.51M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
197.97K
High Today
$2.48
Low Today
$2.26
Open Price
$2.48
Volume
75.23K
52 Week High
$11.00
52 Week Low
$1.83
Collections
Technology
Health
Biotechnology
Medical
2018 IPO
US
North America
Price Paid on Robinhood
23% Lower
Right Now
52 Week Low
$1.83
Average Price Paid
$2.96
52 Week High
$11.00
DFFN Earnings
-$0.90
-$0.62
-$0.34
-$0.06
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 12, After Hours